Target intelligence / Profile preview

CD1d-expressing M2-like macrophage

Molecular classification
Other (Cellular phenotype; not a single molecule but a cell subset defined by both marker expression and polarization state)
01

Overview

CD1d-expressing M2-like macrophages are a subset of anti-inflammatory (M2) macrophages characterized by expression of the lipid-antigen-presenting molecule CD1d, which enables them to present lipid antigens to natural killer T (NKT) cells. This population is found in various tissues, including adipose tissue, where it regulates immune responses, modulates polarization of NKT cells (tending toward Th2/anti-inflammatory responses), and plays important roles in metabolic homeostasis and inflammation. Downregulation of CD1d expression in M2 macrophages has been shown to disrupt immune balance and is implicated in obesity-related metaflammation and insulin resistance. CD1d on these cells is also involved in the regulation of lipid metabolism within macrophages and cross-talk with NKT cells that can impact disease outcomes in metabolic syndrome, inflammation, and potentially tumor environments.

Other names
M2 macrophage expressing CD1dCD1d+ M2 macrophageCD1d-positive M2 macrophage
02

Mechanism of action

Indirect modulation via CD1d ligands (presented by these macrophages to NKT cells, leading to immune modulation); Polarization-shifting therapies (preclinical): modulating macrophage phenotype (e.g., M1↔M2); Immunomodulation by altering NKT–macrophage cross-talk

03

Biological functions

Immune responseAntigen presentation (lipid antigen)Immune regulation (shifting NKT cell responses, promoting Th2 polarization, regulating inflammation and tissue repair)Regulation of lipid metabolism
04

Disease associations

InflammationMetabolic syndrome/obesity-related diseasesInsulin resistance/type 2 diabetesCancer (in context of tumor-associated macrophages, especially M2 subtype)
05

Safety considerations

No specific safety concerns unique to targeting these cells are documented; general concern would be immune suppression if M2-like states are excessively promoted (potential tumor promotion, infection risk)Immune imbalance if CD1d or interactions with NKT cells are inhibited (risking enhanced inflammation or autoimmunity)
06

Interacting drugs

CD1d ligands (e.g., alpha-galactosylceramide)
07

Biomarkers

CD1d cell-surface expression (flow cytometry, immunohistochemistry)M2 macrophage markers: CD163, CD206, CD209, CD204Cytokine profile (IL-10, TGF-β for M2; low IL-12)

Beyond the preview

Go deeper on CD1d-expressing M2-like macrophage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD1d-expressing M2-like macrophage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call